SI · NYSE · Medical - Specialties

Shoulder Innovations (SI)

Builds shoulder arthroplasty implants, planning software, and streamlined procedure tools.

$17.52
vs last close−0.09 (−0.51%)

13F · 13D/G · Form 4

Institutions40.15%8.36M shares
75 holders · as of Jun 30, 2026
Insiders29.55%6.15M shares
12 holders · as of Sep 14, 2026
Strategic holders19.55%4.07M shares
2 holders · as of Aug 28, 2026
Other10.75%2.24M shares
remainder

20.82M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
FMR LLCInstitution
17.65%3.67Mas of Jun 30, 2026
Casey M. TanseyInsiderdirector, 10 percent owner
13.19%2.75Mfiled Jun 29, 2026
Geoffrey B. PardoInsiderdirector, 10 percent owner
11.47%2.39Mfiled Aug 5, 2025
Gilde Healthcare Holding B.V.Strategic10 percent owner
10.50%2.19Mfiled Aug 28, 2026
LSV Associates II, LLC1,2Strategicother: Former 10% Owner
9.05%1.89Mfiled Nov 14, 2025
U.S. Venture Partners XII, L.P.Institution
8.10%1.69Mfiled Nov 14, 2025
Arboretum Ventures VI, L.P.Institution
5.59%1.16Mfiled Aug 8, 2025
BlackRock, Inc.Institution
3.07%638,420as of Jun 30, 2026
Sectoral Asset Management IncInstitution
2.07%430,407as of Jun 30, 2026
Vanguard Capital Management LLCInstitution
1.88%392,181as of Jun 30, 2026
Robert Joseph BallInsiderdirector, officer: CEO & Executive Chairman
1.83%380,824filed Sep 14, 2026
KCM Capital IncInstitution
1.44%300,000as of Jun 30, 2026
Timessquare Capital Management, LLCInstitution
1.43%298,219as of Jun 30, 2026
Roubaix Capital, LLCInstitution
1.23%255,288as of Jun 30, 2026
Driehaus Capital Management LLCInstitution
1.22%253,760as of Jun 30, 2026
Matthew Fraser AhearnInsiderdirector, officer: Chief Operating Officer
1.17%244,176filed Aug 18, 2026
Parkman Healthcare Partners LLCInstitution
1.09%226,212as of Jun 30, 2026
Geode Capital Management, LLCInstitution
0.96%199,529as of Jun 30, 2026
CM Management, LLCInstitution
0.70%145,000as of Jun 30, 2026
David Lawrence BlueInsiderofficer: See Remarks
0.67%139,372filed Jan 8, 2026
JPMorgan Chase & CoInstitution
0.60%124,437as of Jun 30, 2026
Morgan StanleyInstitution
0.56%117,265as of Jun 30, 2026
State Street CorpInstitution
0.55%114,859as of Jun 30, 2026
Hightower Advisors, LLCInstitution
0.49%102,640as of Jun 30, 2026
Jane Street Group, LLCInstitution
0.41%86,307as of Jun 30, 2026
  1. LSV Associates II, LLC's transaction reports restate only vehicles that traded; the 2025 ownership statement (1.89M) is used instead.
  2. LSV Associates II, LLC reports a block also reported by another filer; it is counted once, under that filer.

13F, as of Jun 30, 2026

75 holders · 8.36M shares · 27 new positions · 57 increased · 11 reduced · 10 closed

HolderShares% outstandingChg q/qFiled
FMR LLC3.67M17.65%−110.6KAug 13, 2026
BlackRock, Inc.638.4K3.07%+82.4KAug 7, 2026
Sectoral Asset Management Inc430.4K2.07%0Aug 14, 2026
Vanguard Capital Management LLC392.2K1.88%−21.3KAug 13, 2026
KCM Capital Inc300.0K1.44%+265.0KAug 12, 2026
Timessquare Capital Management, LLC298.2K1.43%−24.5KAug 7, 2026
Roubaix Capital, LLC255.3K1.23%−1.8KAug 10, 2026
Driehaus Capital Management LLC253.8K1.22%+253.8KnewAug 14, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
FMR LLC19.00%3.85M13GSep 8, 2025
Gilde Healthcare V Management B.V.incl. Gilde Healthcare Holding B.V., Manapouri B.V. +2 more10.70%2.21M13DAug 7, 2026
LSV Associates II, LLC9.30%1.89M13GNov 14, 2025
U.S. Venture Partners XII, L.P.8.20%1.69M13GNov 14, 2025
Arboretum Ventures VI, L.P.5.80%1.16M13GAug 8, 2025

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Sep 14, 2026
Robert Joseph Balldirector, officer: CEO & Executive Chairman
Sale10,175$18.45380,824
Aug 26, 2026
Gilde Healthcare Holding B.V.10 percent owner
Sale1,196$22.602,185,914
Aug 24, 2026
Gilde Healthcare Holding B.V.10 percent owner
Sale681$22.622,187,110
Aug 21, 2026
Gilde Healthcare Holding B.V.10 percent owner
Sale20,516$22.612,187,791
Aug 20, 2026
Gilde Healthcare Holding B.V.10 percent owner
Sale3,900$22.602,208,307
Aug 18, 2026
Matthew Fraser Ahearndirector, officer: Chief Operating Officer
Sale · 2 lots14,186$20.99244,176
Aug 17, 2026
Matthew Fraser Ahearndirector, officer: Chief Operating Officer
Sale8,314$20.10258,362
Aug 6, 2026
Gilde Healthcare Holding B.V.10 percent owner
Sale2,095$22.602,212,207
Aug 5, 2026
Gilde Healthcare Holding B.V.10 percent owner
Sale7,338$22.642,214,302
Aug 4, 2026
Gilde Healthcare Holding B.V.10 percent owner
Sale99,812$22.772,221,640

House and Senate disclosures

Not reported.